On August 31, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of both the Moderna Covid-19 injection and the Pfizer-BioNTech Covid-19 injection. The EUAs now include the use of new “bivalent vaccines”, also known as “updated boosters”, that contain mRNA from the original strain of SARS-CoV-2 as well as a shared mRNA component of the BA.4 and BA.5 lineages of the Omicron variant.
These regulatory agencies have neglected to inform the public that no human studies were done before the approval of the new “updated boosters” and that the clinical study referenced included only eight mice. This is both unprecedented and reckless.